Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026)

Phibro Animal Health has reported Cash & Current Investments for 14 years, with the latest figure at $82.0 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 6.43% year-over-year to $82.0 million in Q2 2026; TTM through Jun 2026 was $82.0 million, a 6.43% increase from a year earlier, with the FY2026 full-year figure at $82.0 million, up 6.43% from the prior year.
• Cash & Current Investments was $82.0 million for Q2 2026 at Phibro Animal Health, up from $77.5 million in the prior quarter.
• The five-year high for Cash & Current Investments was $114.6 million in Q2 2024, with the low at $67.1 million in Q4 2024.
• Average Cash & Current Investments over 5 years is $84.9 million, with a median of $83.6 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments surged 41.01% in 2024, then slumped 32.78% in 2025.
• Over 5 years, Cash & Current Investments stood at $78.4 million in 2022, then gained by 17.94% to $92.5 million in 2023, then declined by 27.48% to $67.1 million in 2024, then rose by 11.08% to $74.5 million in 2025, then advanced by 10.05% to $82.0 million in 2026.
• The last three Cash & Current Investments figures came in at $82.0 million (Q2 2026), $77.5 million (Q1 2026), and $74.5 million (Q4 2025), per Business Quant data.